Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
85.37
-1.10 (-1.27%)
At close: Apr 28, 2026, 4:00 PM EDT
85.65
+0.28 (0.33%)
Pre-market: Apr 29, 2026, 5:34 AM EDT
Apogee Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Market Capitalization | 6,304 | 5,094 | 2,578 | 1,342 | - |
| Market Cap Growth | 241.30% | 97.62% | 92.14% | - | - |
| Enterprise Value | 5,410 | 4,515 | 1,836 | 919 | - |
| Last Close Price | 85.37 | 75.48 | 45.30 | 27.94 | - |
| PB Ratio | 6.46 | 5.64 | 3.60 | 3.53 | - |
| P/TBV Ratio | 6.97 | 5.64 | 3.60 | 3.53 | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.02 | 0.01 | - |
| Net Debt / Equity Ratio | -0.99 | -0.99 | -1.00 | -1.04 | -1.07 |
| Net Debt / EBITDA Ratio | 3.15 | 3.15 | 3.32 | - | - |
| Net Debt / FCF Ratio | 3.84 | 3.84 | 4.17 | 5.25 | 8.48 |
| Quick Ratio | 26.38 | 26.38 | 18.40 | 19.30 | 15.22 |
| Current Ratio | 26.57 | 26.57 | 18.55 | 19.38 | 15.24 |
| Return on Equity (ROE) | -31.57% | -31.57% | -33.22% | -32.18% | - |
| Return on Assets (ROA) | -21.11% | -21.11% | -23.46% | -21.00% | - |
| Return on Capital Employed (ROCE) | -31.40% | -31.40% | -29.90% | -24.40% | -23.60% |
| Earnings Yield | -4.06% | -5.02% | -7.07% | -6.26% | - |
| FCF Yield | -3.69% | -4.57% | -6.69% | -5.58% | - |
| Buyback Yield / Dilution | -9.96% | -9.96% | -120.72% | -915.57% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.